
The First Trust SMID Growth Strength ETF (the "Fund") aims to deliver investment performance that broadly matches the price movements and income generation (before accounting for the Fund's own fees and expenses) of an equity benchmark, specifically The SMID Growth Strength Index (the "Index"). Ordinarily, the Fund will allocate a minimum of 80% of its net assets (which may include funds borrowed for investment purposes) to the securities that constitute this Index.
Is FSGS's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

HONG KONG, July 8, 2026 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) announced the closing of its previously announced exclusive licensing and collaborat

HONG KONG, June 4, 2026 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) announced that it has entered into an exclusive licensing and collaboration agreemen

Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that it has entered into an exclusive licensing and collaboration agreement with Everest Medicines f